Ireland· IE-PA-EU/1/01/176/004
Zometa
A medicinal product containing zoledronic acid, registered in Ireland by Phoenix Labs.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Zoledronic acid
- Manufacturer
- Phoenix Labs
- Country
- Ireland (IE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/01/176/004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zoledronic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAclastaSandoz Pharmaceuticals d.d.
- United StatesReclastSandoz Inc
- United KingdomAclasta 5mg/100ml solution for infusion bottlesSandoz Ltd
- BelgiumAcide Zoledronique Regiomedica 4 mg/5 mlRegiomedica
- GermanyAszoraAnwerina Deutschland Gmbh
- CzechiaACLASTASandoz Pharmaceuticals d.d., Ljubljana
- SpainACIDO ZOLEDRONICO ACCORD 4 MG/100 ML SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- NetherlandsAclasta, oplossing voor infusie 5 mg/100 mlSandoz Pharmaceuticals d.d.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
- Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
- Cyprus · Nordeloz, Zoledronic Acid Altan
- Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
- Germany · Aszora, Clastizol
- Denmark · Zoledo, Zoledronsyre Fresenius Kabi
- Estonia · Zoledronic Acid Fresenius Kabi
- Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Finland · Zobiore, Zoledronic Acid Fresenius Kabi
- France · Acide Zoledronique Altan, Acide Zoledronique Biogaran
- United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
- Greece · Bonevin, Nordeloz
- Croatia · Zolenat
- Hungary · Osporil, Zoledronsav Fresenius Kabi
- Iceland · Aclasta, Aszora
- Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
- Liechtenstein · Aclasta, Zoledronic Acid Accord
- Lithuania · Zoledronic Acid Fresenius Kabi
- Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Latvia · Zoledronic Acid Fresenius Kabi
- Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
- Norway · Aclasta, Zoledo
- Poland · Osporil, Zerlinda
- Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
- Sweden · Zerlinda, Zoledronic Acid Accord
- Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
- Slovakia · Kyselina, Kyselina Zoledrónová Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2a13031-81f7-423c-854c-12ad7c9d9763 GET /v1/drugs/c2a13031-81f7-423c-854c-12ad7c9d9763?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"routes": null,
"source": "hpra",
"atc_all": null,
"strength": null,
"pa_number": "EU/1/01/176/004",
"substances": [
"Zoledronic acid"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "24/03/2003",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about zoledronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.